PROGRESS PHARMA (Public limited company)
PROGRESS PHARMA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0536.258.560. It was founded on 27-06-2013. Its registered office is in Vosselaar. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 47 137 and a loss of € 5 479. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 09-10-2026.
Company information
Key figures of PROGRESS PHARMA
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -5 479-88 % | € -2 921-65 % | € -1 775-27 % | € -1 402 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 47 137-49 % | € 92 616-3 % | € 95 537-2 % | € 97 312 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 49 934-47 % | € 94 048-3 % | € 96 647-1 % | € 97 848 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -4 893-108 % | € -2 351-100 % | € -1 173-25 % | € -941 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - | - |
Financial estimate
- 1 Subsidiaries
- 3 Board links
Similar companies
Other companies in the same activity in Vosselaar.
| Company | Town |
|---|---|
| Spine4G | 2350 Vosselaar |
| DR. PETER DRIESEN | 2350 Vosselaar |
| S-QURE | 2350 Vosselaar |
| Dr. Dirven werner | 2350 Vosselaar |
| ANCULARE | 2350 Vosselaar |
| Dr Clerinx Kristien | 2350 Vosselaar |
| Karos Healthcare Consulting | 2350 Vosselaar |
| AlchemAI | 2350 Vosselaar |
Frequently asked questions
Is PROGRESS PHARMA still active? Yes. The Crossroads Bank for Enterprises lists PROGRESS PHARMA as active.
What is the VAT number of PROGRESS PHARMA? The VAT number of PROGRESS PHARMA is BE 0536.258.560.
When was PROGRESS PHARMA founded? PROGRESS PHARMA was founded on 27-06-2013.
What is the address of PROGRESS PHARMA? The current registered office of PROGRESS PHARMA is Roekendreef 14, 2350 Vosselaar.
When did PROGRESS PHARMA last file annual accounts? The latest annual accounts of PROGRESS PHARMA were filed on 05-06-2026.
Does PROGRESS PHARMA file its annual accounts on time? Yes. PROGRESS PHARMA filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is PROGRESS PHARMA financially healthy? Addrly gives PROGRESS PHARMA a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is PROGRESS PHARMA profitable? The annual accounts of PROGRESS PHARMA for 2025 show a loss of € 5 479.
What is the equity of PROGRESS PHARMA? The equity of PROGRESS PHARMA was € 47 137 at the close of the 2025 financial year.
Who are the directors of PROGRESS PHARMA? The annual accounts of PROGRESS PHARMA record 8 mandates. The names, roles and dates are visible with a free account.
Can PROGRESS PHARMA receive Peppol e-invoices? Yes. PROGRESS PHARMA is registered on the Peppol network and can receive structured electronic invoices.
What does PROGRESS PHARMA do? The main activity of PROGRESS PHARMA is: Scientific research and development.